Pure Global AI
ANVISA registration 10259610177Active

ANTIBODY ANTI-EXTRACTABLE NUCLEAR ANTIGENS (ENA)

ANVISA Registration Number: 10259610177MEDIVAX INDÚSTRIA E COMÉRCIO LTDAAESKU DIAGNOSTICSRisk Class II
Verified
Device names
Technical name
ANTIBODY ANTI-EXTRACTABLE NUCLEAR ANTIGENS (ENA)
View exact technical-name matches →
PT: ANTICORPO ANTI-ANTÍGENOS NUCLEARES EXTRAÍVEIS (ENA)
Commercial name
AESKULISA SS-B
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
10259610177
Process Number
25351582897201609
CNPJ
68814961000173
Company information
Registration Holder
MEDIVAX INDÚSTRIA E COMÉRCIO LTDA
Manufacturer
AESKU DIAGNOSTICS
Manufacturing Country
Germany
PT: ALEMANHA
Dates and status
Publication Date
Jul 10, 2017
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTIBODY ANTI-EXTRACTABLE NUCLEAR ANTIGENS (ENA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10259610177 and manufactured by AESKU DIAGNOSTICS. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.